glp-1 medication competitors pharmaceutical companies Comparing Ozempic, Wegovy and Other Drugs GLP-1 Receptor Agonist Market Size

For instance, according to the latest International Diabetes Federation (IDF) Diabetes Atlas (2025), approximately 11.1% of adults aged 2079 yearsabout 1 in 9 peopleare living with diabetes globally, and more than 4 in 10 of those individuals remain undiagnosed

GLP-1 receptor agonists are primarily used to treat type 2 diabetes by lowering blood sugar and reducing food intake

After primary HSV infection, the virus colonises sensory neurons, and the infection may reactivate causing recurrent sub-clinical or clinical infection

Neurological benefits including improved outcomes in demyelinating disease models point to CNS effects

The salads, broth-based soups, and protein bowls What Should I Order at Sweetgreen on GLP-1